HopeStage
Back to all studies
TerminatedNCT00169039

Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia

Medication studyAges 19–60United States
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 19 years to 60 years. Other eligibility criteria apply.

Listed locations
Jamaica PlainSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateDecember 1994
Recruitment status
Terminated
Enrollment listed in the registry
66
Sponsor
Harvard Medical School (HMS and HSDM)
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 19 Years to 60 Years
Official registry ID
NCT00169039
Official title
Show the full official title

Clozapine Response and Biogenic Amines in Schizophrenia

Recruitment & locations

Terminated

Jamaica Plain

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Harvard Medical School (HMS and HSDM).

Does this study involve medication?

Yes. The study involves medication, including Clozapine and Chlorpromazine.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 19 years to 60 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies